[Form 4] Huron Consulting Group Inc. Insider Trading Activity
Rhea-AI Filing Summary
Huron Consulting Group Inc. (HURN) director Hugh E. Sawyer III reported a sale of 400 shares of the company's common stock on 09/02/2025 at a price of $136.21 per share. The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2025, and occurred automatically under that plan. Following the reported sale, Mr. Sawyer beneficially owned 23,262 shares directly. The Form 4 was signed by an attorney-in-fact, Hope Katz, on 09/04/2025.
Positive
- Transaction executed under a Rule 10b5-1 plan, which supports non-opportunistic trading and governance controls.
- Clear disclosure of post-transaction holdings: 23,262 shares directly beneficially owned, aiding investor transparency.
- Form signed by attorney-in-fact (Hope Katz) providing proper execution and traceability.
Negative
- Insider sale of 400 shares reduces director's direct holdings.
- No additional context provided on whether this sale materially affects insider ownership percentage or voting control.
Insights
TL;DR: Routine, pre-planned insider sale under a 10b5-1 plan; disclosure supports governance transparency.
The filing documents an automatic sale of 400 shares by a company director under a Rule 10b5-1 plan adopted March 6, 2025. Use of an established trading plan reduces concerns about opportunistic timing and demonstrates adherence to insider trading controls. The reported remaining direct ownership of 23,262 shares is disclosed, and the form is duly executed by an attorney-in-fact, providing the required signature and traceability.
TL;DR: Small, scheduled disposal unlikely to be material to valuation; disclosure is standard Section 16 reporting.
The sale price of $136.21 for 400 shares is disclosed explicitly and the transaction is coded as executed under a 10b5-1 plan, indicating it was pre-arranged. The filing provides clear post-transaction holdings of 23,262 shares, allowing investors to track insider ownership trends. There is no indication in the filing of derivative transactions or other material changes beyond the single planned sale.